Is RMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-22, ResMed Inc. (NYSE: RMD) is rated A- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 81/100 at a spot price of $236.92 (-2.35% 1D, market cap $33.32B). Pillar breakdown: Fundamental Cash Engine 19/20, Institutional 13F & Options Flow 13/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 14/20, and Executive Insider Alignment 17/20. Across 1015 tracked Health Care issuers, RMD ranks #6 in composite RQD confidence.